Morgan M - Search Results

1

CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies.

Abdin SM, Paasch D, Morgan M, Lachmann N. Abdin SM, et al. Among authors: morgan m. J Immunother Cancer. 2021 Aug;9(8):e002741. doi: 10.1136/jitc-2021-002741. J Immunother Cancer. 2021. PMID: 34462325 Free PMC article.

2

Retroviral Vectors for Cancer Gene Therapy.

Schambach A, Morgan M. Schambach A, et al. Among authors: morgan m. Recent Results Cancer Res. 2016;209:17-35. doi: 10.1007/978-3-319-42934-2_2. Recent Results Cancer Res. 2016. PMID: 28101685 Review.

3

Chimeric Antigen Receptor T Cells: Extending Translation from Liquid to Solid Tumors.

Morgan MA, Schambach A. Morgan MA, et al. Hum Gene Ther. 2018 Oct;29(10):1083-1097. doi: 10.1089/hum.2017.251. Epub 2018 Aug 29. Hum Gene Ther. 2018. PMID: 30156435 Review.

4

Engineering CAR-T Cells for Improved Function Against Solid Tumors.

Morgan MA, Schambach A. Morgan MA, et al. Front Immunol. 2018 Oct 29;9:2493. doi: 10.3389/fimmu.2018.02493. eCollection 2018. Front Immunol. 2018. PMID: 30420856 Free PMC article. Review.

5

Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.

Kloess S, Oberschmidt O, Dahlke J, Vu XK, Neudoerfl C, Kloos A, Gardlowski T, Matthies N, Heuser M, Meyer J, Sauer M, Falk C, Koehl U, Schambach A, Morgan MA. Kloess S, et al. Among authors: morgan ma. Hum Gene Ther. 2019 Apr;30(4):381-401. doi: 10.1089/hum.2018.247. Epub 2019 Mar 18. Hum Gene Ther. 2019. PMID: 30734584

6

Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.

Oberschmidt O, Morgan M, Huppert V, Kessler J, Gardlowski T, Matthies N, Aleksandrova K, Arseniev L, Schambach A, Koehl U, Kloess S. Oberschmidt O, et al. Among authors: morgan m. Hum Gene Ther Methods. 2019 Jun;30(3):102-120. doi: 10.1089/hgtb.2019.039. Epub 2019 May 16. Hum Gene Ther Methods. 2019. PMID: 30997855 Free PMC article.

7

Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells.

Hoffmann D, Kuehle J, Lenz D, Philipp F, Zychlinski D, Lachmann N, Moritz T, Steinemann D, Morgan M, Skokowa J, Klein C, Schambach A. Hoffmann D, et al. Among authors: morgan m. Gene Ther. 2020 Jun;27(6):297-306. doi: 10.1038/s41434-020-0127-y. Epub 2020 Feb 12. Gene Ther. 2020. PMID: 32051561

8

Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.

Morgan MA, Büning H, Sauer M, Schambach A. Morgan MA, et al. Front Immunol. 2020 Aug 7;11:1965. doi: 10.3389/fimmu.2020.01965. eCollection 2020. Front Immunol. 2020. PMID: 32903482 Free PMC article. Review.

9

Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages.

Hoffmann D, Sens J, Brennig S, Brand D, Philipp F, Vollmer Barbosa P, Kuehle J, Steinemann D, Lenz D, Buchegger T, Morgan M, Falk CS, Klein C, Lachmann N, Schambach A. Hoffmann D, et al. Among authors: morgan m. J Pers Med. 2021 Mar 20;11(3):221. doi: 10.3390/jpm11030221. J Pers Med. 2021. PMID: 33804706 Free PMC article.

10

Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants.

Dahlke J, Schott JW, Vollmer Barbosa P, Klatt D, Selich A, Lachmann N, Morgan M, Moritz T, Schambach A. Dahlke J, et al. Among authors: morgan m. J Pers Med. 2021 Jun 17;11(6):565. doi: 10.3390/jpm11060565. J Pers Med. 2021. PMID: 34204193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,049 results

Search Page